Laboratory Earnings Estimate

LH Stock  USD 239.53  3.88  1.65%   
The next projected EPS of Laboratory is estimated to be 3.7734 with future projections ranging from a low of 3.57 to a high of 3.988. Laboratory's most recent 12-month trailing earnings per share (EPS TTM) is at 8.84. Please be aware that the consensus of earnings estimates for Laboratory of is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Laboratory is projected to generate 3.7734 in earnings per share on the 31st of March 2025. Laboratory earnings estimates show analyst consensus about projected Laboratory of EPS (Earning Per Share). It derives the highest and the lowest estimates based on Laboratory's historical volatility. Many public companies, such as Laboratory, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Laboratory's earnings estimates, investors can diagnose different trends across Laboratory's analyst sentiment over time as well as compare current estimates against different timeframes. As of now, Laboratory's Gross Profit Margin is decreasing as compared to previous years.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Laboratory Earnings Estimation Breakdown

The calculation of Laboratory's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Laboratory is estimated to be 3.7734 with the future projection ranging from a low of 3.57 to a high of 3.988. Please be aware that this consensus of annual earnings estimates for Laboratory of is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
3.45
3.57
Lowest
Expected EPS
3.7734
3.99
Highest

Laboratory Earnings Projection Consensus

Suppose the current estimates of Laboratory's value are higher than the current market price of the Laboratory stock. In this case, investors may conclude that Laboratory is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Laboratory's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
1997.15%
3.45
3.7734
8.84

Laboratory Earnings History

Earnings estimate consensus by Laboratory analysts from Wall Street is used by the market to judge Laboratory's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Laboratory's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Laboratory Quarterly Gross Profit

896.3 Million

As of now, Laboratory's Price Earnings To Growth Ratio is increasing as compared to previous years. The Laboratory's current Common Stock Shares Outstanding is estimated to increase to about 95.9 M. The Laboratory's current Net Income Applicable To Common Shares is estimated to increase to about 1.5 B.
Hype
Prediction
LowEstimatedHigh
238.47239.55240.63
Details
Intrinsic
Valuation
LowRealHigh
215.58271.31272.39
Details
Naive
Forecast
LowNextHigh
228.31229.38230.46
Details
19 Analysts
Consensus
LowTargetHigh
237.84261.36290.11
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Laboratory. Your research has to be compared to or analyzed against Laboratory's peers to derive any actionable benefits. When done correctly, Laboratory's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Laboratory. Note that many institutional investors and large investment bankers can move markets due to the volume of Laboratory assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Laboratory. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Laboratory's stock price in the short term.

Laboratory Earnings per Share Projection vs Actual

Actual Earning per Share of Laboratory refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Laboratory of predict the company's earnings will be in the future. The higher the earnings per share of Laboratory, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Laboratory Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Laboratory, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Laboratory should always be considered in relation to other companies to make a more educated investment decision.

Laboratory Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Laboratory's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-13
2024-12-313.39213.450.0579
2024-10-24
2024-09-303.483.50.02
2024-07-25
2024-06-303.83.940.14
2024-04-25
2024-03-313.483.680.2
2024-02-15
2023-12-313.263.30.04
2023-10-26
2023-09-303.333.380.05
2023-07-27
2023-06-303.533.80.27
2023-04-25
2023-03-313.963.82-0.14
2023-02-16
2022-12-314.14.140.04
2022-10-27
2022-09-304.674.680.01
2022-07-28
2022-06-304.74.950.25
2022-04-28
2022-03-315.986.110.13
2022-02-10
2021-12-315.86.770.9716 
2021-10-28
2021-09-304.926.821.938 
2021-07-29
2021-06-305.536.130.610 
2021-04-29
2021-03-317.438.791.3618 
2021-02-11
2020-12-318.1110.562.4530 
2020-10-27
2020-09-305.318.413.158 
2020-07-28
2020-06-3012.571.57157 
2020-04-29
2020-03-311.952.370.4221 
2020-02-13
2019-12-312.82.860.06
2019-10-24
2019-09-302.852.90.05
2019-07-25
2019-06-302.922.930.01
2019-04-30
2019-03-312.532.620.09
2019-02-07
2018-12-312.492.520.03
2018-10-24
2018-09-302.882.84-0.04
2018-07-25
2018-06-302.932.980.05
2018-04-25
2018-03-312.632.780.15
2018-02-06
2017-12-312.382.450.07
2017-10-25
2017-09-302.392.460.07
2017-07-26
2017-06-302.42.470.07
2017-04-25
2017-03-312.22.220.02
2017-02-16
2016-12-312.132.150.02
2016-10-26
2016-09-302.292.25-0.04
2016-07-27
2016-06-302.32.310.01
2016-04-25
2016-03-311.962.020.06
2016-02-18
2015-12-311.991.98-0.01
2015-10-26
2015-09-302.062.070.01
2015-07-28
2015-06-302.032.090.06
2015-04-27
2015-03-311.631.730.1
2015-02-20
2014-12-311.631.650.02
2014-10-28
2014-09-301.751.80.05
2014-07-18
2014-06-301.771.780.01
2014-04-28
2014-03-311.581.51-0.07
2014-02-07
2013-12-311.661.61-0.05
2013-10-18
2013-09-301.81.80.0
2013-07-19
2013-06-301.81.80.0
2013-04-19
2013-03-311.761.74-0.02
2013-02-08
2012-12-311.621.630.01
2012-10-18
2012-09-301.741.760.02
2012-07-19
2012-06-301.771.770.0
2012-04-19
2012-03-311.671.740.07
2012-02-10
2011-12-311.531.560.03
2011-10-20
2011-09-301.61.610.01
2011-07-21
2011-06-301.631.640.01
2011-04-21
2011-03-311.461.520.06
2011-02-10
2010-12-311.311.340.03
2010-10-21
2010-09-301.41.470.07
2010-07-22
2010-06-301.421.460.04
2010-04-21
2010-03-311.311.3-0.01
2010-02-11
2009-12-311.151.160.01
2009-10-22
2009-09-301.151.220.07
2009-07-23
2009-06-301.271.30.03
2009-04-23
2009-03-311.171.220.05
2009-02-12
2008-12-311.091.10.01
2008-10-23
2008-09-301.121.1-0.02
2008-07-24
2008-06-301.241.240.0
2008-04-24
2008-03-311.141.140.0
2008-02-07
2007-12-311.011.040.03
2007-10-25
2007-09-301.091.07-0.02
2007-07-24
2007-06-301.091.090.0
2007-04-26
2007-03-310.930.980.05
2007-02-15
2006-12-310.720.850.1318 
2006-10-24
2006-09-300.80.840.04
2006-07-25
2006-06-300.830.870.04
2006-04-25
2006-03-310.740.760.02
2006-02-16
2005-12-310.650.670.02
2005-10-20
2005-09-300.720.7-0.02
2005-07-21
2005-06-300.750.760.01
2005-04-19
2005-03-310.650.670.02
2005-02-15
2004-12-310.610.610.0
2004-10-21
2004-09-300.660.660.0
2004-07-22
2004-06-300.660.70.04
2004-04-22
2004-03-310.590.610.02
2004-02-12
2003-12-310.530.530.0
2003-10-23
2003-09-300.590.590.0
2003-07-22
2003-06-300.60.60.0
2003-04-28
2003-03-310.490.510.02
2003-02-18
2002-12-310.360.360.0
2002-10-30
2002-09-300.440.460.02
2002-07-24
2002-06-300.540.550.01
2002-04-22
2002-03-310.460.470.01
2002-02-13
2001-12-310.270.290.02
2001-10-22
2001-09-300.340.370.03
2001-07-23
2001-06-300.350.370.02
2001-04-23
2001-03-310.310.310.0
2001-02-14
2000-12-310.150.08-0.0746 
2000-10-23
2000-09-300.20.240.0420 
2000-07-19
2000-06-300.220.240.02
2000-04-24
2000-03-310.110.180.0763 
1999-10-20
1999-09-300.080.080.0
1999-07-22
1999-06-300.130.150.0215 
1999-04-22
1999-03-310.050.050.0
1999-02-23
1998-12-31-0.02-0.28-0.261300 
1998-10-27
1998-09-30-0.020.0020.022110 
1998-07-21
1998-06-30-0.040.030.07175 
1998-04-30
1998-03-31-0.1-0.020.0880 
1998-03-17
1997-12-31-0.12-0.10.0216 
1997-10-28
1997-09-30-0.07-0.12-0.0571 
1997-07-29
1997-06-300.060.05-0.0116 
1997-04-25
1997-03-310.10.05-0.0550 
1997-02-20
1996-12-3100.030.03
null
nullnullnullnull
1996-08-01
1996-06-300.320.13-0.1959 
1996-04-25
1996-03-310.190.13-0.0631 
1996-02-12
1995-12-310.380.18-0.252 
1995-10-24
1995-09-300.30.30.0

About Laboratory Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Laboratory earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Laboratory estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Laboratory fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings8.3 B8.7 B
Retained Earnings Total Equity12 B12.6 B
Earnings Yield 0.04  0.03 
Price Earnings Ratio 25.70  26.98 
Price Earnings To Growth Ratio 0.30  0.31 

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
2.88
Earnings Share
8.84
Revenue Per Share
155.052
Quarterly Revenue Growth
0.098
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.